These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31627908)

  • 1. No Advantage of Expanded Polytetrafluoroethylene and Fluorinated Ethylene Propylene-Covered Stents over Uncovered Nitinol Stents for Percutaneous Palliation of Malignant Infrahilar Biliary Obstruction: Results of a Single-Center Prospective Randomized Trial.
    Dhondt E; Vanlangenhove P; De Man M; Huyck L; Defreyne L
    J Vasc Interv Radiol; 2020 Jan; 31(1):82-92. PubMed ID: 31627908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence of improved efficacy of covered stents over uncovered stents in percutaneous palliation of malignant hilar biliary obstruction: results of a prospective randomized trial.
    Dhondt E; Vanlangenhove P; Geboes K; Vandenabeele L; Van Cauwenberghe L; Defreyne L
    Eur Radiol; 2020 Jan; 30(1):175-185. PubMed ID: 31385047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous palliation of pancreatic head cancer: randomized comparison of ePTFE/FEP-covered versus uncovered nitinol biliary stents.
    Krokidis M; Fanelli F; Orgera G; Tsetis D; Mouzas I; Bezzi M; Kouroumalis E; Pasariello R; Hatzidakis A
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):352-61. PubMed ID: 20467870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of malignant biliary obstruction: technical and clinical results using an expanded polytetrafluoroethylene fluorinated ethylene propylene (ePTFE/FEP)-covered metallic stent after 6-year experience.
    Fanelli F; Orgera G; Bezzi M; Rossi P; Allegritti M; Passariello R
    Eur Radiol; 2008 May; 18(5):911-9. PubMed ID: 18204844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study.
    Kullman E; Frozanpor F; Söderlund C; Linder S; Sandström P; Lindhoff-Larsson A; Toth E; Lindell G; Jonas E; Freedman J; Ljungman M; Rudberg C; Ohlin B; Zacharias R; Leijonmarck CE; Teder K; Ringman A; Persson G; Gözen M; Eriksson O
    Gastrointest Endosc; 2010 Nov; 72(5):915-23. PubMed ID: 21034892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.
    Kitano M; Yamashita Y; Tanaka K; Konishi H; Yazumi S; Nakai Y; Nishiyama O; Uehara H; Mitoro A; Sanuki T; Takaoka M; Koshitani T; Arisaka Y; Shiba M; Hoki N; Sato H; Sasaki Y; Sato M; Hasegawa K; Kawabata H; Okabe Y; Mukai H
    Am J Gastroenterol; 2013 Nov; 108(11):1713-22. PubMed ID: 24042190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction.
    Bezzi M; Zolovkins A; Cantisani V; Salvatori FM; Rossi M; Fanelli F; Rossi P
    J Vasc Interv Radiol; 2002 Jun; 13(6):581-9. PubMed ID: 12050298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reintervention for occluded metal stent in malignant bile duct obstruction: A prospective randomized trial comparing covered and uncovered metal stent.
    Lee BS; Ryu JK; Jang DK; Chung KH; Yoon WJ; Kim J; Woo SM; Lee SH; Lee WJ; Kim YT
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1901-1907. PubMed ID: 27029890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Salvage Percutaneous Biliary Drainage after Occlusion of Endoscopic Stents.
    Kessler J; Lee A; Frankel P; Dagis A; Park JJ; Lin J
    J Vasc Interv Radiol; 2017 Apr; 28(4):594-601. PubMed ID: 28169138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients.
    Sakai Y; Iwai T; Shimura K; Gon K; Koizumi K; Ijima M; Chiba K; Nakatani S; Sugiyama H; Tsuyuguchi T; Kamisawa T; Maetani I; Kida M
    World J Gastroenterol; 2018 Jan; 24(1):69-75. PubMed ID: 29358883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant biliary obstruction with a PTFE-covered self-expandable nitinol stent.
    Han YM; Kwak HS; Jin GY; Lee SO; Chung GH
    Korean J Radiol; 2007; 8(5):410-7. PubMed ID: 17923784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Study of Percutaneous Transhepatic Biliary Stent Placement with or without Iodine-125 Seeds for Treating Patients with Malignant Biliary Obstruction.
    Hasimu A; Gu JP; Ji WZ; Zhang HX; Zhu DW; Ren WX
    J Vasc Interv Radiol; 2017 Apr; 28(4):583-593. PubMed ID: 28162906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents.
    Moses PL; Alnaamani KM; Barkun AN; Gordon SR; Mitty RD; Branch MS; Kowalski TE; Martel M; Adam V
    World J Gastroenterol; 2013 Dec; 19(46):8638-46. PubMed ID: 24379581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of covered versus uncovered metallic stents in treating inoperable malignant common bile duct obstruction: a randomized trial.
    Lee SJ; Kim MD; Lee MS; Kim IJ; Park SI; Won JY; Lee DY
    J Vasc Interv Radiol; 2014 Dec; 25(12):1912-20. PubMed ID: 25085230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluation.
    Ferlitsch A; Oesterreicher C; Dumonceau JM; Deviere J; Leban T; Born P; Rösch T; Suter W; Binek J; Meyenberger C; Müllner M; Schneider B; Schöfl R
    Endoscopy; 2001 Aug; 33(8):645-50. PubMed ID: 11490378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant biliary obstruction: treatment with ePTFE-FEP- covered endoprostheses initial technical and clinical experiences in a multicenter trial.
    Schoder M; Rossi P; Uflacker R; Bezzi M; Stadler A; Funovics MA; Cejna M; Lammer J
    Radiology; 2002 Oct; 225(1):35-42. PubMed ID: 12354981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients.
    Li M; Li K; Qi X; Wu W; Zheng L; He C; Yin Z; Fan D; Zhang Z; Han G
    J Vasc Interv Radiol; 2016 Jul; 27(7):1047-1055.e2. PubMed ID: 27241392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of occluded self-expanding biliary metal stents in malignant biliary disease.
    Nennstiel S; Tschurtschenthaler I; Neu B; Algül H; Bajbouj M; Schmid RM; von Delius S; Weber A
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):49-54. PubMed ID: 29428104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous unilateral biliary metallic stent placement in patients with malignant obstruction of the biliary hila and contralateral portal vein steno-occlusion.
    Son RC; Gwon DI; Ko HK; Kim JW; Ko GY
    Korean J Radiol; 2015; 16(3):586-92. PubMed ID: 25995688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous unilateral placement of biliary covered metallic stent in patients with malignant hilar biliary obstruction and contralateral portal vein occlusion.
    Yi R; Gwon DI; Ko GY; Yoon HK; Kim JH; Shin JH; Sung KB
    Acta Radiol; 2012 Sep; 53(7):742-9. PubMed ID: 22850575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.